UBS Group’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.97M | Buy |
816,945
+371,813
| +84% | +$830K | ﹤0.01% | 4991 |
|
|
2025
Q4 | $890K | Buy |
445,132
+242,287
| +119% | +$574K | ﹤0.01% | 5675 |
|
|
2025
Q3 | $619K | Buy |
202,845
+161,317
| +388% | +$503K | ﹤0.01% | 5928 |
|
|
2025
Q2 | $105K | Buy |
41,528
+392
| +1% | +$938 | ﹤0.01% | 7205 |
|
|
2025
Q1 | $62.1K | Buy |
41,136
+40,062
| +3,730% | +$70.8K | ﹤0.01% | 7413 |
|
|
2024
Q4 | $1.2K | Sell |
1,074
-43,429
| -98% | -$42.5K | ﹤0.01% | 9289 |
|
|
2024
Q3 | $39.8K | Buy |
44,503
+44,493
| +444,930% | +$43.4K | ﹤0.01% | 6966 |
|
|
2024
Q2 | $10 | Hold |
10
| – | – | ﹤0.01% | 9358 |
|
|
2024
Q1 | $12 | Buy |
10
+3
| +43% | +$4 | ﹤0.01% | 9078 |
|
|
2023
Q4 | $11 | Sell |
7
-1
| -13% | -$1 | ﹤0.01% | 9112 |
|
|
2023
Q3 | $11 | Sell |
8
-9,098
| -100% | -$19.7K | ﹤0.01% | 9200 |
|
|
2023
Q2 | $24.8K | Buy |
9,106
+4,559
| +100% | +$9.13K | ﹤0.01% | 6784 |
|
|
2023
Q1 | $9.46K | Buy |
4,547
+2,980
| +190% | +$8.82K | ﹤0.01% | 7655 |
|
|
2022
Q4 | $4.72K | Buy |
1,567
+962
| +159% | +$3.99K | ﹤0.01% | 9290 |
|
|
2022
Q3 | $3K | Sell |
605
-993
| -62% | -$5.11K | ﹤0.01% | 9556 |
|
|
2022
Q2 | $8K | Buy |
1,598
+1,596
| +79,800% | +$8.88K | ﹤0.01% | 8324 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 10631 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 10512 |
|
|
2021
Q3 | $0 | Sell |
2
-535
| -100% | -$3.88K | ﹤0.01% | 9850 |
|
|
2021
Q2 | $4K | Buy |
537
+225
| +72% | +$1.7K | ﹤0.01% | 8675 |
|
|
2021
Q1 | $3K | Buy |
312
+310
| +15,500% | +$2.67K | ﹤0.01% | 8524 |
|
|
2020
Q4 | $0 | Sell |
2
-2,173
| -100% | -$16.3K | ﹤0.01% | 8597 |
|
|
2020
Q3 | $17K | Buy |
2,175
+2,172
| +72,400% | +$15.3K | ﹤0.01% | 6444 |
|
|
2020
Q2 | $0 | Sell |
3
-3,088
| -100% | -$20.9K | ﹤0.01% | 8184 |
|
|
2020
Q1 | $17K | Buy |
3,091
+3,083
| +38,538% | +$27K | ﹤0.01% | 6591 |
|
|
2019
Q4 | $0 | Sell |
8
-2,009
| -100% | -$11.8K | ﹤0.01% | 8295 |
|
|
2019
Q3 | $11K | Sell |
2,017
-252
| -11% | -$1.47K | ﹤0.01% | 7106 |
|
|
2019
Q2 | $12K | Buy |
2,269
+2,128
| +1,509% | +$14.1K | ﹤0.01% | 6949 |
|
|
2019
Q1 | $1K | Sell |
141
-6,206
| -98% | -$48.2K | ﹤0.01% | 7549 |
|
|
2018
Q4 | $11K | Buy |
6,347
+6,341
| +105,683% | +$24K | ﹤0.01% | 7185 |
|
|
2018
Q3 | $0 | Sell |
6
-672
| -99% | -$5.8K | ﹤0.01% | 8138 |
|
|
2018
Q2 | $7K | Sell |
678
-1,081
| -61% | -$13.2K | ﹤0.01% | 7339 |
|
|
2018
Q1 | $17K | Buy |
1,759
+1,055
| +150% | +$14.3K | ﹤0.01% | 6509 |
|
|
2017
Q4 | $11K | Buy |
704
+700
| +17,500% | +$11.9K | ﹤0.01% | 6959 |
|
|
2017
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 7885 |
|
|
2017
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 7851 |
|
|
2017
Q1 | $0 | Sell |
4
-47
| -92% | -$4.13K | ﹤0.01% | 7830 |
|
|
2016
Q4 | $4K | Sell |
51
-96
| -65% | -$12.1K | ﹤0.01% | 7324 |
|
|
2016
Q3 | $27K | Buy |
147
+144
| +4,800% | +$18.8K | ﹤0.01% | 6035 |
|
|
2016
Q2 | $0 | Sell |
3
-23
| -88% | -$6.63K | ﹤0.01% | 7868 |
|
|
2016
Q1 | $11K | Buy |
26
+20
| +333% | +$10.6K | ﹤0.01% | 6600 |
|
|
2015
Q4 | $4K | Buy |
6
+2
| +50% | +$1.47K | ﹤0.01% | 7780 |
|
|
2015
Q3 | $3K | Hold |
4
| – | – | ﹤0.01% | 7944 |
|
|
2015
Q2 | $4K | Sell |
4
-3
| -43% | -$3.53K | ﹤0.01% | 7978 |
|
|
2015
Q1 | $11K | Buy |
7
+1
| +17% | +$1.79K | ﹤0.01% | 7559 |
|
|
2014
Q4 | $9K | Buy |
+6
| New | +$10.9K | ﹤0.01% | 8485 |
|
Other funds holding MBOT
VCM
CBU
AA
UBS Group's MBOT Position: Q1 2026 in Review
UBS Group increased its Microbot Medical (MBOT) stake by 84% in Q1 2026, buying an estimated $830K and bringing the position to 816,945 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #4991.
UBS Group first reported a position in MBOT in Q4 2014 and has held it in 46 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.
- UBS Group held 816,945 shares of Microbot Medical worth $1.97M as of Q1 2026.
- UBS Group bought 371,813 Microbot Medical shares in Q1 2026, an estimated $830K.
- Microbot Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4991 holding.
- UBS Group first reported a position in Microbot Medical in Q4 2014 and has held it in 46 quarters since.
- 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.